Geopolitics Alpha

Women's Health; Advancement Efforts To Improve Outcomes in All Phases of Life (EO 14437)

Published . Updated .

Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Please visit FederalRegister.gov API documentation or eCFR.gov API documentation to learn more about how to access

Directly affected

  • No company is named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    A fund of health-care companies

  • XBI SPDR S&P Biotech

    A fund of biotechnology companies

  • UNH UnitedHealth

    A large health insurer

  • JNJ Johnson & Johnson

    A large health-care company

  • LLY Eli Lilly

    A large drug maker

  • PFE Pfizer

    A large drug maker

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
XLV———————
XBI———————
UNH———————
JNJ———————
LLY———————
PFE———————

Women's Health; Advancement Efforts To Improve Outcomes in All Phases of Life (EO 14437)

Source: federal-register-public-inspection

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Women's Health; Advancement Efforts To Improve Outcomes in All Phases of Life (EO 14437)” scores 12 out of 100. The score uses 1 sources.